Determinants of Virological Failure Among Patients on First-line Antiretroviral Therapy in Central Oromia, Ethiopia: A Case–Control Study

References

• Joint United Nations Programme on HIV/AIDS (UNAIDS). GLOBAL AIDS UPDATE 2017, Ending AIDS, Progress Towards the 90–90–90 Targets. 2017.
   Google Scholar
• UNAIDS. Joint United Nations Programme on HIV/AIDS UNAIDS. UNAIDS; 2017.
   Google Scholar
• World Health Organization. Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. 2017.
   Google Scholar
• Ministry of Health, Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and Treatment. 2018.
   Google Scholar
• The Ethiopian Public Health Institute. HIV Related Estimates and Projections for Ethiopia–2017. Addis Ababa, Ethiopia; 2017.
   Google Scholar
• The Ethiopian Public Health Institute. HIV Related Estimates andProjections for Ethiopia. 2015.
   Google Scholar
• World Health Organization. Guidelines on the Public Health Response to Pretreatment HIV Drug Resistance. 2017.
   Google Scholar
• Ministry of Health, Federal Democratic Republic of Ethiopia. National Guidelines for Comprehensive Hiv Prevention, Care and Treatment. 2018.
   Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing Hiv Infection: Recommendations for a Public Health Approach. 2016.
   Google Scholar
• Arnaout RA, Lloyd AL, O’Brien TR, et al. A simple relationship between viral load and survival time in HIV-1 infection. Proc Natl Acad Sci. 1999;96(20):11549–11553. doi:10.1073/pnas.96.20.1154910500214
   PubMedGoogle Scholar
• UNAIDS. Global AIDS Updates. 2017.
   Google Scholar
• UNAIDS. Global AIDS Update 2018, Miles To Go, Closing Gaps Breaking Barriers, Righting Injustices. 2018.
   Google Scholar
• Gill MM, Hoffman HJ, Bobrow EA, et al. Detectable viral load in late pregnancy among women in the Rwanda option B+ PMTCT program: enrollment results from the Kabeho study. PLoS One. 2016;11(12):e0168671. doi:10.1371/journal.pone.016867128006001
   PubMedGoogle Scholar
• Zoufaly A, Jochum J, Hammerl R, et al. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon. J Antimicrob Chemother. 2015;70(3):922–925. doi:10.1093/jac/dku47025428920
   PubMedGoogle Scholar
• Etta EM, Mavhandu L, Manhaeve C, et al. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa. AIDS Res Ther. 2017;14(1). doi:10.1186/s12981-017-0161-z.
   PubMed Web of Science ®Google Scholar
• Townsend D, Troya J, Maida I. et al. First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome. J Int Assoc Physicians AIDS Care. 2009;8:314–317.
   Google Scholar
• Endalamaw A, Mekonen M, Geremew D, Ambaw F, Tesera H, Habtewold TD. Still poor HAART adherence has great impact on HIV/AIDS treatment failure in Ethiopia. biorxiv. 2018. doi:10.1101/440743.
   Google Scholar
• Amani-Bosse C, Dahourou DL, Malateste K, et al. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. J Int AIDS Soc. 2017;20(1):21362. doi:10.7448/IAS.20.01.2136228453240
   PubMedGoogle Scholar
• Mulisa D, Tesfa M, Mullu Kassa G, Tolossa T. Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study. BMC Infect Dis. 2019;19(1):1024. doi:10.1186/s12879-019-4651-631795955
   PubMed Web of Science ®Google Scholar
• Zoufaly A, Jochum J, Hammerl R, et al. Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon. J Int AIDS Soc. 2014;17:19615. doi:10.7448/IAS.17.4.1961525394119
   PubMedGoogle Scholar
• Oromia Regional Health Bureau. Performance Review for HIV Epidemic Control, 2016–2017 Finfinne/Addis Ababa, Ethiopia. 2017.
   Google Scholar
• CDC. Epi Info TM 7 User Guide. Vol. 645 2016.
   Google Scholar
• Bayu B, Tariku A, Bulti A, et al. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar referral hospital, Northwest Ethiopia: a case–control study. HIV AIDS (Auckl). 2017;9:153–159. doi:10.2147/HIV.S13951628848364
   PubMedGoogle Scholar
• Kwobah M, Mwangi CW, Koech AK, Simiyu JN, M. Siika A. Factors associated with first-line antiretroviral therapy failure amongst HIV-infected african patients: a case-control study. World J AIDS. 2012;02(04):271–278. doi:10.4236/wja.2012.24036
   Google Scholar
• Rangarajan S, Colby DJ, Giang LT, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J Virus Eradication. 2016;2(2):8. doi:10.1016/S2055-6640(20)30466-0
   Google Scholar
• Joseph Davey D, Abrahams Z, Feinberg M, et al. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa. Int J STD AIDS. 2018;29(6):603–610. doi:10.1177/095646241774885929334886
   PubMedGoogle Scholar
• Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in uganda, august 2014–july 2015. BMC Infect Dis. 2017;17(1):326. doi:10.1186/s12879-017-2428-328468608
   PubMedGoogle Scholar
• IBM. IBM SPSS Statistics 20 Brief Guide. Vol. 170 2011.
   Google Scholar
• Zhang Z. Model building strategy for logistic regression: purposeful selection. Ann Transl Med. 2016;4:7.26855943
   PubMed Web of Science ®Google Scholar
• Senaviratna NAMR, Cooray A. Diagnosing multicollinearity of logistic regression model. Asian J Probab Stat. 2019;1–9. doi:10.9734/ajpas/2019/v5i230132.
   Google Scholar
• Annual performance report. HIV/AIDS Case Team of Federal Minstry of Health, Ethiopia. 2018.
   Google Scholar
• Barlow-Mosha L, Angelidou K, Lindsey J, et al. Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in hiv-infected infants and young children: long-term follow-up of the IMPAACT p1060 randomized trial. Clin Infect Dis. 2016;63(8):1113–1121. doi:10.1093/cid/ciw48827439527
   PubMedGoogle Scholar
• Crawford K, Wakabi S, Magala F, Kibuuka H, Liu M, Hamm TE. Evaluation of treatment outcomes for patients on first-line regimens in US President’s emergency plan for AIDS relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses: predictors of response to first-line ART from RV288 analysis. HIV Med. 2015;16:95–104.25124078
   PubMed Web of Science ®Google Scholar
• Tanuma J, Matsumoto S, Haneuse S, et al. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam. J Int AIDS Soc. 2017;20(4):e25030. doi:10.1002/jia2.25030
   PubMed Web of Science ®Google Scholar
• Jean Louis F, Buteau J, François K, et al. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti. PLoS One. 2018;13(1):e0192077. doi:10.1371/journal.pone.019207729381736
   PubMedGoogle Scholar
• Cherutich P, Kim AA, Kellogg TA, et al. Detectable HIV viral load in Kenya: data from a population-based survey. PLoS One. 2016;11(5):e0154318. doi:10.1371/journal.pone.015431827192052
   PubMedGoogle Scholar
• Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;9.
   Google Scholar
• Patel R, Ratner J, Gore-Felton C, et al. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2011;24(3):358–368. doi:10.1080/09540121.2011.60878621902570
   PubMedGoogle Scholar
• Daskalopoulou M, Lampe FC, Sherr L, For the ASTRA Study Group. Non-disclosure of HIV status and associations with psychological factors, ART non-adherence, and viral load non-suppression among people living with HIV in the UK. AIDS Behav. 2017;21(1):184–195. doi:10.1007/s10461-016-1541-427586375
   PubMed Web of Science ®Google Scholar
• Krauss B. Guideline on HIV Disclosure Counselling for Children Up to 12 Years of Age. 2011.
   Google Scholar
• Arrivé E, Dicko F, Amghar H, et al. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One. 2012;7(3):e33690. doi:10.1371/journal.pone.003369022457782
   PubMed Web of Science ®Google Scholar
• Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):305. doi:10.1186/s12879-019-3924-430943903
   PubMedGoogle Scholar